Medically tailored meals improved blood sugar and blood pressure in adults with type 2 diabetes
An 8-month medically tailored meals program was associated with better diet quality, lower HbA1c, lower blood pressure, and improved food security in adults living with both type 2 diabetes and hypertension. The findings come from a 110-person study in New York City presented at the American Heart Association’s Scientific Sessions 2026.
The intervention paired meal delivery with nutrition counseling, heart health education, cooking demonstrations, healthy recipes, and bags of fresh produce and ingredients. In practical terms, the package was designed to make healthier eating easier to sustain for people carrying two of the most common and consequential cardiometabolic diagnoses.
The signal was not subtle: participants in both meal groups improved across several clinically relevant measures.
A nutrition intervention built around chronic disease management
The study enrolled adults with type 2 diabetes and hypertension from neighborhoods with high rates of chronic disease and premature death. Participants had an average age of 63 years, 68% were female, 47% identified as Hispanic, and 43% identified as Black. Investigators followed the cohort for 8 months and assessed blood sugar, blood pressure, diet quality, food security, and general health status at the start and end of the intervention.
One group received 10 medically tailored meals per week throughout the study. The second group also began with 10 meals weekly, then the dose tapered by one meal per week each month over the final 5 months until it reached five meals weekly by the last month. Both groups received the same dietitian counseling and educational support, which included culturally responsive cooking demonstrations and guidance aligned with heart-healthy dietary principles.
That design matters because it tested a common real-world question: whether a less intensive meal schedule can still support health gains when the clinical education around it remains strong.
Diet quality, HbA1c, and blood pressure all moved in the favorable direction
Diet quality improved in both groups, with a three-point increase in adherence to a heart-healthy, Mediterranean-style eating pattern. For patients living with diabetes and hypertension, a shift toward a more cardioprotective eating pattern is clinically relevant because dietary intake influences glycemic control, blood pressure, body weight, and downstream cardiovascular risk.
Blood sugar control also improved. HbA1c fell by about 0.5 percentage points, a change that can matter in diabetes care even when it looks modest on paper. A drop of that size suggests better average glycemic control over time and may help reduce the burden of diabetes-related complications if maintained.
Blood pressure improved as well. Both systolic and diastolic measurements decreased by approximately 4 mm Hg. For patients already living with hypertension, even a small reduction in blood pressure can affect cardiovascular risk over time, especially when the improvement is paired with better diet quality and improved access to healthy food.
Food security improved alongside the clinical measures
Food security also improved. Using the six-item U.S. Department of Agriculture food security scale, investigators found that participants in either group were more than twice as likely to achieve a higher food security status after 8 months compared with baseline.
That finding gives the program a broader meaning beyond glucose and blood pressure numbers. It suggests that food-based interventions can affect whether patients actually have dependable access to nutritious meals, not just whether they know what to eat.
For people managing chronic disease on limited budgets, the cost and logistics of healthy eating can be as important as the medical advice itself. A meal program that reduces those barriers may support adherence in a way standard counseling alone often cannot.
Fewer meals did not erase the benefit when education stayed in place
A striking feature of the study was that gradually reducing meal provision did not appear to weaken the main health gains. Participants who moved from 10 meals per week to five by the end of the intervention improved in a way that looked broadly similar to those who continued receiving 10 meals weekly.
The likely explanation is the combined intervention. Meal delivery was paired with a heart health curriculum, counseling, cooking demonstrations, recipes, and healthy ingredients. In other words, the meals were not the only exposure. Participants also received tools intended to help them keep preparing healthy food after the delivered meals diminished.
The results suggest that a lower-dose meal program may still be useful if the educational and practical support is strong enough to help people maintain healthier habits on their own. A single intervention component would be easier to study; this one reflects the more complicated reality of food insecurity and chronic disease management.
Why the findings remain preliminary
The study has important limits. It included only 110 people and was conducted at a single site in New York City, so the results may not generalize to other populations or health systems. Outcomes were measured only at baseline and at 8 months, leaving open the question of whether the gains persist after the program ends.
The design also makes it impossible to separate the effect of the meals from the effect of the counseling, education, cooking demonstrations, and produce support. The intervention was bundled, so the observed benefit likely reflects the combination rather than the meals alone.
Because the work was presented as a conference abstract, it has not yet undergone full peer review. Larger multisite trials will need to confirm whether medically tailored meals can reliably improve cardiometabolic outcomes, identify which patients benefit most, and determine whether reduced meal delivery can preserve results at a lower cost.
The central clinical question is now less about whether food support can help and more about how to deliver it at scale without losing its effect.